In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

The tablets are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Dultra added, "We are proud to continue our mission of delivering high-quality, affordable ...

Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...

OpenCV is a set of libs written in C++ and the compiled into platform-native lib format: *.dll - for Windows, or *.dylib - for Linux / Mac OS. They can be accessed from Java via Java wrapper included ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

A collage showing two bottles of pills against China’s flag and individual pills as the backdrop. A US Pharmacopeia study shows that the US is heavily dependent on China for raw materials needed to ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...